Related content

Inhibition of RIP2/RICK/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK

By Argast Gretchen   Fausto Nelson   Campbell Jean  

Molecular and Cellular Biochemistry, Vol. 268, Iss. 1-2, 2005-01 ,pp. : 129-140

Springer Publishing Company

Access to resources Recommend Favorite

A novel Pd-catalyzed cyclization reaction of ureas for the synthesis of dihydroquinazolinone p38 kinase inhibitors

By Schlapbach A.   Heng R.   Di Padova F.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 357-360

Elsevier

Access to resources Recommend Favorite

p38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1

By Nerurkar S. S.   Olzinski A. R.   Frazier K. S.   Mirabile R. C.   O'Brien S. P.   Jing J.   Rajagopalan D.   Yue T. -L.   Willette R. N.  

Biomarkers, Vol. 12, Iss. 1, 2007-01 ,pp. : 87-112

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors potentiate 1α,25-dihydroxyvitamin D₃-induced monocytic differentiation by activating p38 MAPK pathway

By Stixová Lenka   Procházková Jiřina   Souček Karel   Hofmanová Jiřina   Kozubík Alois  

Molecular and Cellular Biochemistry, Vol. 330, Iss. 1-2, 2009-10 ,pp. : 229-238

Springer Publishing Company

Access to resources Recommend Favorite

Activation of p38 in Stimulated Human Neutrophils: Phosphorylation of the Oxidase Component p47 phox by p38 and ERK but Not by JNK

By Benna J.E.   Han J.   Park J.W.   Schmid E.   Ulevitch R.J.   Babior B.M.  

Archives of Biochemistry and Biophysics, Vol. 334, Iss. 2, 1996-10 ,pp. : 395-400

Elsevier

Access to resources Recommend Favorite